“
***This article is the second of a two-article series which summarises the experiences shared at the WBCPC 2020 Virtual Annual Meeting.
How advocacy helps progress bladder cancer research in the US: an example for inspiration?
Even as the voice of bladder cancer patients is under-represented in many countries today, Dr Stephanie Chisolm, Director of Education and Research, Bladder Cancer Advocacy Network (BCAN), says that science and pharmaceutical innovation to control the disease have progressed steadily since 1900 – and patient perspectives have been present along this entire pathway.
As representatives of nine global cancer coalitions and alliances, representing 750 patient advocacy and other cancer organisations and the interests of over 14 million patientsi around the world, we have united to share the following statement on COVID-19 and call for a global plan of action for cancer to meet the challenges of future pandemics or health crises.
Although in some countries we are seeing encouraging signs that the worst phase of the pandemic is coming to an end albeit with concerns about a potential second wave,
La Coalición Mundial de Pacientes con Cáncer de Vejiga ha publicado un informe sobre el impacto de COVID-19 en las organizaciones de pacientes con cáncer. Este informe es el trabajo de cinco coaliciones mundiales de pacientes con cáncer, que representan a unas 400 organizaciones. Demuestra el entusiasmo y la voluntad de colaborar en un momento muy difícil, para desarrollar y fortalecer los llamamientos a la acción, para aprender unos de otros y apoyar a aquellos con los que trabajamos y a las comunidades a las que servimos.
